Vns - Vitaria
Payments companies reported to CMS as associated with Vns - Vitaria. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Vns - Vitaria, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Vns - Vitaria
These are the largest totals companies reported as associated with Vns - Vitaria. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Marvin Konstam | Boston, MA | Cardiovascular Disease | $15,125.00 |
| Peter Carson | Washington, DC | $8,600.00 | |
| Richard Patten | Burlington, MA | Advanced Heart Failure and Transplant Cardiology | $6,280.00 |
| Paul Hauptman | St Louis, MO | Cardiovascular Disease | $6,140.00 |
| Ayan Patel | Boston, MA | Cardiovascular Disease | $5,280.00 |
| Wayne Levy | Seattle, WA | Advanced Heart Failure and Transplant Cardiology | $4,460.00 |
| Ron Oren | Naperville, IL | Advanced Heart Failure and Transplant Cardiology | $4,200.00 |
| Eugene Chung | Cincinnati, OH | Advanced Heart Failure and Transplant Cardiology | $3,480.00 |
| Barry Greenberg | San Diego, CA | Advanced Heart Failure and Transplant Cardiology | $2,125.00 |
| David Cannom | Los Angeles, CA | Clinical Cardiac Electrophysiology | $2,125.00 |
Prescribed Vns - Vitaria?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.